Jacobs Levy Equity Management’s Neurogene NGNE Stock Holding History

Jacobs Levy Equity Management’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,231	Closed	-$171K	–	851
2015 Q2	$171K	Buy	+1,231	New	+$187K	﹤0.01%	741

Other funds holding NGNE

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jacobs Levy Equity Management's NGNE Position: Q3 2015 in Review

Jacobs Levy Equity Management sold out of Neurogene (NGNE) in Q3 2015, closing a stake of 1,231 shares — an estimated $171K sold.

Jacobs Levy Equity Management first reported a position in NGNE in Q2 2015 and held it in 1 quarter. The position peaked at $171K in Q2 2015. 33 funds tracked by Wall St. Rank hold NGNE as of Q3 2015.

Jacobs Levy Equity Management reported no remaining Neurogene position as of Q3 2015 after selling out during the quarter.
Jacobs Levy Equity Management sold 1,231 Neurogene shares in Q3 2015, an estimated $171K.
Jacobs Levy Equity Management first reported a position in Neurogene in Q2 2015 and held it in 1 quarter.
Jacobs Levy Equity Management's Neurogene position peaked at $171K in Q2 2015.
33 funds tracked by Wall St. Rank held Neurogene as of Q3 2015.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2015, filed 16 Nov 2015.